NO975901L - Vinyl-pyrrolidinon cefalosporiner med basiske substituenter - Google Patents

Vinyl-pyrrolidinon cefalosporiner med basiske substituenter

Info

Publication number
NO975901L
NO975901L NO975901A NO975901A NO975901L NO 975901 L NO975901 L NO 975901L NO 975901 A NO975901 A NO 975901A NO 975901 A NO975901 A NO 975901A NO 975901 L NO975901 L NO 975901L
Authority
NO
Norway
Prior art keywords
formula
cephalosporins
compounds
vinyl pyrrolidinone
basic substituents
Prior art date
Application number
NO975901A
Other languages
English (en)
Norwegian (no)
Other versions
NO975901D0 (no
Inventor
Peter Angehrn
Paul Hebeisen
Ingrid Heinze-Krauss
Malcolm Page
Valurie Runtz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO975901D0 publication Critical patent/NO975901D0/no
Publication of NO975901L publication Critical patent/NO975901L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO975901A 1996-12-19 1997-12-16 Vinyl-pyrrolidinon cefalosporiner med basiske substituenter NO975901L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96120472 1996-12-19
EP97119528 1997-11-07

Publications (2)

Publication Number Publication Date
NO975901D0 NO975901D0 (no) 1997-12-16
NO975901L true NO975901L (no) 1998-06-22

Family

ID=26142379

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975901A NO975901L (no) 1996-12-19 1997-12-16 Vinyl-pyrrolidinon cefalosporiner med basiske substituenter

Country Status (20)

Country Link
US (1) US5981519A (de)
EP (1) EP0849269B9 (de)
JP (2) JP3264877B2 (de)
KR (3) KR100395985B1 (de)
CN (5) CN1183141C (de)
AT (1) ATE220402T1 (de)
AU (1) AU729653B2 (de)
CA (2) CA2628224C (de)
CY (1) CY2400B1 (de)
CZ (1) CZ405797A3 (de)
DE (1) DE69713865T2 (de)
DK (1) DK0849269T3 (de)
ES (1) ES2179996T3 (de)
HU (1) HUP9702474A3 (de)
IL (1) IL122604A0 (de)
MA (1) MA26457A1 (de)
NO (1) NO975901L (de)
NZ (1) NZ329363A (de)
PT (1) PT849269E (de)
TW (1) TW415949B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977381A (en) * 1998-01-12 1999-11-02 Hoffmann-La Roche Inc. Process for making 3-amino-pyrolidine derivatives
JP3872955B2 (ja) * 1998-06-15 2007-01-24 バジリア ファルマスーチカ アーゲー 3−(2−オキソ−〔1,3′〕ビピロリジニル−3−イリデンメチル)−セフェムの誘導体
US6232306B1 (en) * 1998-06-15 2001-05-15 Hoffmann-La Roche Inc. Derivatives of 3-(2-oxo-[1,3′]bipyrrolidinyl-3-ylidenemethyl)-cephams
WO2000032605A1 (en) * 1998-12-03 2000-06-08 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
ATE370146T1 (de) * 1999-07-05 2007-09-15 Basilea Pharmaceutica Ag Verfahren zur herstellung von cephalosporin- derivaten
AU6267100A (en) * 1999-07-07 2001-01-30 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
DK1148140T3 (da) 2000-04-19 2007-01-08 Basilea Pharmaceutica Ag Fremgangsmåde til fremstilling af D-asparaginderivater
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
CN1212327C (zh) * 2000-08-14 2005-07-27 巴斯利尔药物股份公司 N-保护的-3-吡咯烷-内酰胺取代的鏻盐的制备
ITMI20012363A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Metodo per la sintesi di catene laterali di cefalosporine
MXPA05010083A (es) 2003-03-27 2005-11-23 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
WO2005063704A1 (ja) * 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
US7569691B2 (en) * 2005-04-20 2009-08-04 Shin-Etsu Chemical Co., Ltd. Protected piperazino group-bearing organoxysilane compound and making method
CN101245079B (zh) * 2007-02-14 2010-07-07 山东轩竹医药科技有限公司 头孢抗生素衍生物
CN101245081B (zh) * 2007-02-14 2010-10-13 山东轩竹医药科技有限公司 头孢菌素衍生物
CN101835777A (zh) 2007-10-25 2010-09-15 尔察祯有限公司 碳头孢烯β-内酰胺抗生素
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
CN101899059B (zh) * 2009-01-21 2012-02-15 山东轩竹医药科技有限公司 含有吡咯烷并环的头孢菌素衍生物
JP2012528102A (ja) 2009-05-25 2012-11-12 サンド・アクチエンゲゼルシヤフト セフトビプロールメドカリルの製造方法
CN102030766B (zh) * 2009-09-30 2012-08-08 山东轩竹医药科技有限公司 含有二氢吡咯并杂环的头孢抗生素
CN103864851B (zh) * 2014-03-25 2016-08-17 华润赛科药业有限责任公司 作为前药的头孢吡普衍生物及其制备方法和用途
CA3268414A1 (en) 2022-10-10 2024-04-18 Basilea Pharmaceutica International Ag, Allschwil METHODS OF TREATMENT OF INFECTIONS WITH STAPHYLOCOCCUS AUREUS BACTEREMIA

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
CA2147609A1 (en) * 1992-10-23 1994-05-11 Kohji Kawabata Cephem compounds, and their pharmaceutical compositions
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
WO1995009171A1 (en) * 1993-09-29 1995-04-06 Meiji Seika Kaisha, Ltd. Novel cephalosporin derivative
TR199700859T1 (xx) 1995-02-27 1998-02-21 F. Hoffmann-La Roche Ag 3-Pirolidiliden-2-on-sefalosporin t�revleri.
JPH08319291A (ja) * 1995-05-25 1996-12-03 Meiji Seika Kaisha Ltd 新規セフェム誘導体
AT403161B (de) * 1995-07-19 1997-11-25 Biochemie Gmbh Verfahren zur herstellung von cephemverbindungen

Also Published As

Publication number Publication date
KR100331212B1 (ko) 2002-04-03
AU729653B2 (en) 2001-02-08
CA2224438A1 (en) 1998-06-19
CN1198833C (zh) 2005-04-27
US5981519A (en) 1999-11-09
CA2628224A1 (en) 1998-06-19
DK0849269T3 (da) 2002-10-28
JP2002060390A (ja) 2002-02-26
CA2628224C (en) 2010-02-16
ATE220402T1 (de) 2002-07-15
JP4043203B2 (ja) 2008-02-06
CN1347882A (zh) 2002-05-08
JPH10182657A (ja) 1998-07-07
DE69713865T2 (de) 2003-02-20
PT849269E (pt) 2002-11-29
NZ329363A (en) 1999-01-28
AU4846397A (en) 1998-06-25
DE69713865D1 (de) 2002-08-14
CN1347884A (zh) 2002-05-08
CY2400B1 (en) 2004-09-10
CN1132833C (zh) 2003-12-31
KR19980064240A (ko) 1998-10-07
EP0849269B1 (de) 2002-07-10
NO975901D0 (no) 1997-12-16
EP0849269B9 (de) 2003-03-05
CZ405797A3 (cs) 1998-07-15
MA26457A1 (fr) 2004-12-20
JP3264877B2 (ja) 2002-03-11
CN1325850A (zh) 2001-12-12
ES2179996T3 (es) 2003-02-01
CN1188112A (zh) 1998-07-22
TW415949B (en) 2000-12-21
HUP9702474A3 (en) 2001-04-28
IL122604A0 (en) 1998-08-16
EP0849269A1 (de) 1998-06-24
CN1163496C (zh) 2004-08-25
CA2224438C (en) 2009-02-24
CN1183141C (zh) 2005-01-05
HUP9702474A2 (hu) 1998-11-30
HU9702474D0 (en) 1998-03-02
CN1347883A (zh) 2002-05-08
KR100395985B1 (ko) 2004-02-14
KR100310384B1 (ko) 2001-11-08
CN1104436C (zh) 2003-04-02

Similar Documents

Publication Publication Date Title
AU1025795A (en) Prolineamide derivatives
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
NO20004624D0 (no) Benzensulfonamid-derivater og deres anvendelse som medikamenter
NO963053L (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
DK0849269T3 (da) Vinylpyrrolidincephalosporiner med basiske substituenter
HUP0001269A2 (hu) 2-Oxo-1-azetidin-szulfonsav-származékok és ezeket tartalmazó kombinált gyógyszerkészítmények
NO20015172L (no) 1-metyl-erytromycin-derivater
TW375615B (en) Galanthamine derivatives and their use as medicaments
NO911041L (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
PT992509E (pt) Novos derivados macrolidos
DE69302646D1 (de) Benzimidazolverbindungen als Antibiotika gegen Campylobacter pylon
MY135646A (en) Indolyl derivatives
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
AP9801235A0 (en) Erythromycin derivatives.
NO20013601L (no) Nye morfolinobenzamidsalter
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
YU38497A (sh) Derivati 1-karba-(detia)-cefalosporina, njihova proizvodnja, intermedijeri koji se koriste u toj proizvodnji, odgovarajući farmaceutski preparati i upotreba jedinjenja za proizvodnju farmaceutskih preparata
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application